Health-care associated bacteremia in geriatric cancer patients with febrile neutropenia

被引:6
|
作者
Aydemir, Hande [1 ]
Piskin, Nihal [1 ]
Kokturk, Furuzan [2 ]
Gokmen, Ayla [3 ]
Akduman, Deniz [1 ]
机构
[1] Bulent Ecevit Univ, Fac Med, Dept Infect Dis & Clin Microbiol, TR-67600 Zonguldak, Turkey
[2] Bulent Ecevit Univ, Fac Med, Dept Biostat, TR-67600 Zonguldak, Turkey
[3] Bulent Ecevit Univ, Fac Med, Dept Hematol, TR-67600 Zonguldak, Turkey
关键词
Bacteremia; Neutropenia; Malignant; Febrile neutropenia; Elderly; Mortality; BLOOD-STREAM INFECTIONS; MULTINATIONAL ASSOCIATION; SUPPORTIVE CARE; RISK FEBRILE; DEFINITIONS; COHORT;
D O I
10.1016/j.jgo.2012.10.174
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim of this study was to determine the epidemiology, clinical manifestations, and outcome of health-care associated bacteremia in geriatric cancer patients with febrile neutropenia. Materials and Methods: We retrospectively evaluated cancer patients with febrile neutropenia aged >= 60 years with culture proven health-care associated bacteremia between January 2005 and December 2011. The date of the first positive blood culture was regarded as the date of bacteremia onset. Primary outcome was the infection related mortality, defined as the death within 14 days of bacteremia onset. Results: The two most common pathogens responsible for bacteremia were Staphylococcus epidermidis (36.1%) and Escherichia coli (31.5%), with high rates of methicillin resistance and extended-spectrum beta-lactamase (ESBL) production, respectively. There were no statistically significant differences in infection related mortality rate according to the type of malignancy (p=0.776). By the univariate analysis, factors associated with 14 day mortality among febrile neutropenic episodes were prolonged neutropenia (p=0.024), persistent fever (p=0.001), hospitalization in ICU (p<0.001) and the initial clinical presentations including respiratory failure (p<0.001), hepatic failure (p=0.013), hematological failure (p<0.001), neurological failure (p<0.001), severe sepsis (p<0.001), and septic shock (p=0.036). Multivariate analysis showed that persistent fever was an independent factor associated with infection related mortality (odds ratio, 18.0; 95% confidence interval, 5.2-62.6; p<0.001). Conclusions: The only independent risk factor for mortality was persistent fever. Although the most frequently isolated pathogens were S. epidermidis and E. coli, high rates of methicillin resistance and ESBL production were found respectively. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:190 / 195
页数:6
相关论文
共 50 条
  • [31] Chronic comorbid conditions associated with risk of febrile neutropenia in breast cancer patients treated with chemotherapy
    Victoria M. Chia
    John H. Page
    Roberto Rodriguez
    Su-Jau Yang
    Julie Huynh
    Chun Chao
    Breast Cancer Research and Treatment, 2013, 138 : 621 - 631
  • [32] The use of serum endothelial adhesion molecules in pediatric patients with leukemia with febrile neutropenia to predict bacteremia
    Arikan, Kamile
    Karadag-Oncel, Eda
    Aytac, Selin
    Cengiz, Ali Bulent
    Cetinkaya, Fahriye Duygu
    Kara, Ates
    Ceyhan, Mehmet
    CYTOKINE, 2021, 148
  • [33] Costs associated with febrile neutropenia in solid tumor and lymphoma patients - an observational study in Singapore
    Wang, Xiao Jun
    Wong, Mabel
    Hsu, Li Yang
    Chan, Alexandre
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [34] Bacterial infection profiles in lung cancer patients with febrile neutropenia
    Jean-Philippe Lanoix
    Emilie Pluquet
    Francois Xavier Lescure
    Houcine Bentayeb
    Emmanuelle Lecuyer
    Marie Boutemy
    Patrick Dumont
    Vincent Jounieaux
    Jean Luc Schmit
    Charles Dayen
    Youcef Douadi
    BMC Infectious Diseases, 11
  • [35] A Prospective Study of Febrile Neutropenia in Pediatric Cancer Patients in Jordan
    Al Omar, Suha
    Nazer, Lama
    Alkayed, Khaldoun
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (08) : 614 - 617
  • [36] Risk of Mortality in Patients With Cancer Who Experience Febrile Neutropenia
    Lyman, Gary H.
    Michels, Shannon L.
    Reynolds, Matthew W.
    Barron, Rich
    Tomic, Karen Smoyer
    Yu, Jingbo
    CANCER, 2010, 116 (23) : 5555 - 5563
  • [37] Bloodstream infections in cancer patients with febrile neutropenia
    Feld, Ronald
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 : S30 - S33
  • [38] The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score
    Chaftari, Patrick
    Chaftari, Anne-Marie
    Hachem, Ray
    Yeung, Sai-Ching J.
    Dagher, Hiba
    Jiang, Ying
    Malek, Alexandre E.
    Dailey Garnes, Natalie
    Mulanovich, Victor E.
    Raad, Issam
    CANCER MEDICINE, 2021, 10 (23): : 8475 - 8482
  • [39] Evaluation and management of febrile neutropenia in patients with cancer
    Cossey, Jason
    Cote, Mary Claire B.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2024, 37 (08): : 16 - 20
  • [40] Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia
    Baskaran, Nirmala Devi
    Gan, Gin Gin
    Adeeba, Kamarulzaman
    Sam, I-Ching
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (06) : 513 - 517